We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Guava Unveils ViaCount™ Assay

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Guava Technologies Inc. has unveiled the ViaCount™ assay. The Guava ViaCount assay is designed to addresse many of the difficulties of conventional cell counting and viability assessment methods.

The Guava ViaCount™ assay provides cell counts and viability determination based on the differential uptake of fluorescent reagents. 

The Guava ViaCount assay uses proprietary Guava software, and reagent kits optimised for use with the Guava PCA and PCA-96 systems. 

Guava claims that, using a Guava Personal Cell Analysis system, with ViaCount™ reagent, customer can automatically obtain absolute cell counts and viability results.